Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305 USD | -0.22% | -0.27% | +5.90% |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Jun. 06 | Transcript : Amgen Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.90% | 164B | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
-0.73% | 162B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170